Pfizer Inc. (PFE) Stock Forecast & Predictions

Pfizer Inc. PFE: $37.17

235 E 42nd St, New York, New York, US. | Sector: Manufacturing | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: https://www.pfizer.com/

  • Market Cap$207.32B
  • Change (52 Weeks)7.63%
  • Low (52 Weeks)$30.65
  • Pfizer Inc. (PFE) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 18.75% are on Buy, 31.25% on Sell, and 50.00% Neutral.

    According to the market data, Pfizer Inc. (PFE) stock price is $37.17 and the 52 weeks low is $30.65, which means the Pfizer Inc. stock price is up 7.63% in the last 12 months.

    Pfizer Inc. (PFE) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 18.75% are indicating that PFE Stock price might rise further, 31.25% indicating that PFE Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall PFE stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Pfizer Inc. (PFE) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Pfizer Inc. (PFE) is based on 26 Institutional Analyst Ratings where 26.92% are on Strong Buy, 11.54% on Moderate Buy, 61.54% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 26 Institutional Analysts, majority recommended PFE stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Pfizer Inc..

    Pfizer Inc. (PFE) Stock Price Prediction By Analysts


    HighLowAverage
    $55.65$36.36$41.35
    $41.3511.25% Upside
    Updated: 2021-04-12 00:00:00

    The Average Price target for PFE set by the institutional analysts is $41.35 where High Estimate is $55.65, Median $39.78 and Low $36.36.

    The average price target for PFE by Institutional Analysts is $41.35, which is 11.25% Upside from the current price. So according to the Institutional Analysts, PFE Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Pfizer Inc. (PFE) Stock Forecast Based on News Sentiment


    Bullish
    Based on 240 articles published Last Week, where 78.57% are Bullish and 21.43% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked positively about PFE, it shows that Pfizer Inc. had a 78.57% positive news coverage.

    Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that PFE stock price may surge in the next few weeks.

    Pfizer Inc. (PFE) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    SVB LeerinkMarket PerformMaintained
    DZ BankBuyUpgraded
    SVB LeerinkMarket PerformMaintained
    MizuhoBuyMaintained
    Morgan StanleyEqual-WeightMaintained
    RBC CapitalSector PerformDowngraded
    Goldman SachsNeutralReiterated
    BernsteinMarket PerformInitiated
    SVB LeerinkMarket PerformMaintained
    Truist SecuritiesBuyInitiated
    Atlantic EquitiesNeutralDowngraded
    BerenbergHoldInitiated
    Morgan StanleyEqual-WeightMaintained
    UBSNeutralMaintained
    SVB LeerinkMarket PerformMaintained
    SVB LeerinkMarket PerformInitiated
    JP MorganNeutralMaintained
    BarclaysEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    RBC CapitalOutperformMaintained
    BarclaysEqual-WeightInitiated
    MizuhoBuyInitiated
    RBC CapitalOutperformInitiated
    DZ BankHoldUpgraded
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightDowngraded
    Bank of AmericaNeutralDowngraded
    Bank of AmericaBuyMaintained
    Credit SuisseOutperformUpgraded
    ArgusOutperformUpgraded
    UBSNeutralDowngraded
    JP MorganNeutralDowngraded
    CitigroupSellMaintained
    BMO CapitalMarket PerformDowngraded
    Credit SuisseNeutralMaintained
    Morgan StanleyOverweightMaintained
    BarclaysEqual-WeightMaintained
    Credit SuisseNeutralMaintained
    BMO CapitalOutperformMaintained
    Bank of AmericaBuyMaintained
    BMO CapitalOutperformMaintained
    BarclaysEqual-WeightDowngraded
    Morgan StanleyOverweightMaintained
    Leerink SwannMarket PerformMaintained
    Credit SuisseNeutralMaintained
    BarclaysOverweightMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyOverweightUpgraded
    BMO CapitalOutperformUpgraded
    Credit SuisseNeutralMaintained
    CitigroupSellDowngraded
    GuggenheimNeutralInitiated
    BarclaysOverweightUpgraded
    BMO CapitalMarket PerformDowngraded
    ArgusHoldDowngraded
    JefferiesHoldDowngraded
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    BerenbergHoldInitiated
    Credit SuisseOutperformMaintained
    Leerink SwannMarket PerformMaintained
    Leerink SwannMarket PerformMaintained
    JefferiesBuyMaintained
    Societe GeneraleHoldInitiated
    SunTrust Robinson HumphreyNeutralMaintained
    ArgusBuyMaintained
    JefferiesBuyMaintained
    Atlantic EquitiesOverweightInitiated
    SunTrust Robinson HumphreyNeutralUpgraded
    ArgusBuyMaintained
    Cowen & Co.OutperformUpgraded
    Morgan StanleyOverweightUpgraded
    JefferiesBuyMaintained
    PiperJaffrayOverweightInitiated
    JefferiesOverweightInitiated
    JP MorganOverweightMaintained
    Deutsche BankBuyMaintained
    JefferiesBuyMaintained
    Deutsche BankBuyMaintained
    JefferiesBuyMaintained
    JP MorganOverweightMaintained
    CitigroupBuyMaintained
    BMO CapitalOutperformUpgraded
    Deutsche BankBuyMaintained
    JefferiesBuyMaintained
    Deutsche BankBuyInitiated
    BMO CapitalMarket PerformDowngraded
    JefferiesBuyMaintained
    BarclaysEqual-WeightMaintained
    Credit SuisseOutperformMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    JefferiesBuyMaintained
    Morgan StanleyOverweightMaintained
    SunTrust Robinson HumphreyReduceMaintained
    Bank of AmericaBuyMaintained
    JefferiesBuyUpgraded
    Atlantic EquitiesOverweightMaintained
    Cowen & Co.Market PerformDowngraded
    Morgan StanleyOverweightMaintained
    LBBW ResearchBuyUpgraded
    Credit SuisseOutperformInitiated
    JefferiesHoldDowngraded
    Standpoint ResearchSellDowngraded
    JefferiesBuyMaintained
    SunTrust Robinson HumphreyInitiated
    BMO CapitalOutperformMaintained
    JefferiesBuyMaintained
    Morgan StanleyOverweightMaintained
    Bank of AmericaBuyMaintained
    UBSBuyMaintained
    JP MorganOverweightMaintained
    Goldman SachsBuyMaintained
    BMO CapitalOutperformMaintained
    Hilliard LyonsLong-Term BuyMaintained
    BMO CapitalOutperformMaintained
    JefferiesBuyMaintained
    JP MorganOverweightMaintained
    CitigroupBuyInitiated
    CitigroupBuyMaintained
    MKM PartnersNeutralDowngraded
    JefferiesBuyMaintained
    BMO CapitalOutperformMaintained
    BarclaysEqual-WeightMaintained
    JefferiesBuyMaintained
    Morgan StanleyOverweightMaintained
    JefferiesBuyMaintained
    Bank of AmericaBuyMaintained
    Morgan StanleyOverweightMaintained
    JefferiesBuyMaintained
    ISI GroupBuyInitiated
    CitigroupNeutralMaintained
    Goldman SachsBuyMaintained

    Pfizer Inc. (PFE) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.873
    The average consensus EPS for PFE is $0.873 with a high estimate of $1.260 and Low of $0.774 for the period 2021-06-30 and based on 14 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $0.72$0.72105922020-09-30


    The latest average Earning Per Share Estimate for Pfizer Inc. is $0.87, which is higher than PFE's last EPS, $0.72. This means that Analysts are expecting Pfizer Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Pfizer Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $0.72$0.72105922020-09-30
    $0.78$0.6700342020-06-30
    $0.8$0.74174400000000012020-03-31
    $0.55$0.5825682019-12-31
    $0.75$0.6243822019-09-30
    $0.8$0.76012600000000012019-06-30
    $0.85$0.75878272019-03-31
    $0.64$0.63878462018-12-31
    $0.78$0.75375290000000012018-09-30
    $0.81$0.75165212018-06-30
    $0.77$0.75217732018-03-31
    $0.62$0.56738772017-12-31
    $0.67$0.65126822017-09-30
    $0.67$0.66413562017-06-30
    $0.69$0.67838672017-03-31
    $0.47$0.50544442016-12-31
    $0.61$0.62272562016-09-30
    $0.64$0.62988652016-06-30
    $0.67$0.55733822016-03-31
    $0.53$0.52654329999999992015-12-31
    $0.6$0.51150442015-09-30
    $0.56$0.51981672015-06-30
    $0.51$0.4984352015-03-31
    $0.54$0.53363352014-12-31
    $0.57$0.55776242014-09-30
    $0.58$0.57121559999999992014-06-30
    $0.57$0.55825730000000012014-03-31
    $0.56$0.52799772013-12-31
    $0.58$0.56387292013-09-30
    $0.56$0.55617672013-06-30
    $0.54$0.56042880000000012013-03-31
    $0.47$0.44629882012-12-31
    $0.53$0.530252012-09-30
    $0.62$0.54828862012-06-30
    $0.58$0.56916532012-03-31
    $0.5$0.473578899999999972011-12-31
    $0.62$0.56081262011-09-30
    $0.6$0.5933752011-06-30
    $0.6$0.59114292011-03-31
    $0.47$0.46300422010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).